Navigation Links
PharMEDium Adds O.R. Medication Verification System
Date:12/12/2011

NEW ORLEANS, Dec. 12, 2011 /PRNewswire/ -- PharMEDium announced the first generation solution designed to support medication safety and documentation in the Operating Room (O.R.).  PharMEDium has developed the first bar code scanner to support medication verification administration.  "Our certiMED™ system is designed to be used with the extensive line of PharMEDium Ready-to-Use O.R. syringe medications by providing a visual and audible double check at the point of administration," said David Jonas, PharMEDium Chairman and CEO.

In the O.R., anesthesia providers prepare and administer critical medications in a complex environment.  The certiMED™ scanner is designed to function as an extension to the market leading PharMEDium O.R. anesthesia syringe labels featuring the American Society of Anesthesiologists' endorsed ASTM color standard to differentiate drugs within a class (http://www.asahq.org/For-Healthcare-Professionals/Standards-Guidelines-and-Statements.aspx).  The certiMED™ scanner was also developed with pharmacy requirements in mind.  certiMED™ provides a means to reconcile medications in real time while supporting the anesthesia provider by integrating pharmacy resources into the medication use process in the O.R. through the drug library.

The Anesthesia Patient Safety Foundation (APSF) held a summit on Medication Safety in the Operating Room in 2010.  The outcome was a set of recommendations encompassed by the acronym S.T.P.C. or Standardization, Technology, Prefilled/Pharmacy/Premixed and Culture of Safety (http://www.apsf.org/newsletters/pdf/spring_2010.pdf).  With the addition of the certiMED™ system, PharMEDium now can offer a combined solution to support the overall implementation of the APSF recommendations.  The APSF Technology recommendation calls for "providing anesthetizing locations with a mechanism to identify medications before drawing up or administering them (bar code reader) and a mechanism to provide feedback and decision support…" (http://www.apsf.org/newsletters/pdf/spring_2010.pdf).  The certiMED™ scanner can directly support the implementation of this recommendation by confirming that the intended Ready-to-Use prefilled PharMEDium syringe was selected correctly.

PharMEDium is the national leading provider of pharmacy sterile intravenous admixture compounding services. The PharMEDium network of state licensed and federally registered compounding centers provides trusted solutions to hospitals throughout the United States. PharMEDium complies with all applicable state laws and federal regulations, including USP Chapter (797), and DEA requirements.  For more information on PharMEDium, visit www.pharmedium.com.

 


'/>"/>
SOURCE PharMEDium
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. PharMEDium Elects William R. Spalding to Board of Directors
2. PharMEDium Hires Thomas W. Rasnic as Vice President, Quality, Regulatory Affairs and Research and Development
3. PharMEDium Announces Propofol, Ready-to-Use, Single Patient, Syringe Service for Operating Room Anesthesia
4. PharMEDium Becomes a Corporate Supporter of the American Society of Anesthesiologists (ASA)
5. PharMEDium Services, LLC Receives U.S. Patent 7,918,830 Entitled Safety Device for Drug Delivery Devices and Containers
6. PharMEDium Unveils Drug Shortage and Usage Updates on New Website with Focus on Patient Safety
7. PharMEDiums Technology Helps Hospital Pharmacists Ensure Safety
8. Wedgewood Introduces Refresh(TM) Exchange-Program: Free Exchange of Expired Veterinary Compounded Medications Solves Key Industry Problem
9. More Than 1.5 Million Americans Sickened, Injured or Killed by Medication Errors Each Year; Seniors Most at Risk
10. RICE MEMORIAL HOSPITAL PHARMACY STAFF EXPERIENCES A 55% REDUCTION IN TIME SPENT MANAGING PATIENT-SPECIFIC MEDICATIONS USING OMNICELL SINGLEPOINTE SOLUTION
11. Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017  Zimmer Biomet Holdings, ... musculoskeletal healthcare, today announced that it will be participating ... Conference at the InterContinental Hotel in Boston, ... Biomet will present at 11:20 a.m. Eastern Time. ... accessed via Zimmer Biomet,s Investor Relations website at ...
(Date:4/20/2017)... -- Research and Markets has announced the addition of ... Expanding Injectables Market and Increasing Usage of Complex Biologics during the ... ... from USD 20 Billion in 2015 to around USD 26 Billion ... Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage of ...
(Date:4/20/2017)...  AbbVie (NYSE: ABBV), a global biopharmaceutical company, ... hepatitis C virus (HCV) infected patients with genotype ... cirrhosis (Child-Pugh A) achieved sustained virologic response at ... investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high ... weeks of G/P treatment without ribavirin. Patients with ...
Breaking Medicine Technology:
(Date:4/25/2017)... KY (PRWEB) , ... April 25, 2017 , ... ... announce they have signed an agreement to be the preferred physical therapy provider ... injuries and returning them to Derby City CrossFit as quickly and effectively as ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... compare student test score performance for the 2015-16 school year across Wisconsin’s public ... programs. Though it highlights important patterns in student test score performance, the report’s ...
(Date:4/25/2017)... ... 25, 2017 , ... As pharmaceutical companies are held to ... process innovation in drug formulation and manufacturing. CoreRx offers its clients more ... in support of their development and manufacturing goals. , The company was ...
(Date:4/25/2017)... ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed to providing the ... or chronic problems, I focus on preventative care with all my patients to alleviate possible ... questions, always feel free to contact my office and my trained staff will assist you ...
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol USA® , a ... UCII, part of the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event ... the immunologic level. , The scientifically-developed Flexadin UCII supports the body’s normal repair ...
Breaking Medicine News(10 mins):